Thomas Köhnke

2.5k total citations
46 papers, 1.8k citations indexed

About

Thomas Köhnke is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Thomas Köhnke has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 17 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Thomas Köhnke's work include Acute Myeloid Leukemia Research (23 papers), CAR-T cell therapy research (15 papers) and Acute Lymphoblastic Leukemia research (8 papers). Thomas Köhnke is often cited by papers focused on Acute Myeloid Leukemia Research (23 papers), CAR-T cell therapy research (15 papers) and Acute Lymphoblastic Leukemia research (8 papers). Thomas Köhnke collaborates with scholars based in Germany, United States and India. Thomas Köhnke's co-authors include Marion Subklewe, Christina Krupka, Felix S. Lichtenegger, Karsten Spiekermann, Ravindra Majeti, Klaus H. Metzeler, Sascha Haubner, Wolfgang Hiddemann, Johanna Tischer and Stephanie Schneider and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Thomas Köhnke

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Köhnke Germany 21 902 754 637 532 241 46 1.8k
Éric Jourdan France 18 1.3k 1.4× 570 0.8× 733 1.2× 568 1.1× 407 1.7× 54 2.1k
Enkhtsetseg Purev United States 21 551 0.6× 755 1.0× 768 1.2× 308 0.6× 193 0.8× 55 1.6k
Shinichi Mizuno Japan 16 698 0.8× 405 0.5× 1.0k 1.6× 316 0.6× 210 0.9× 46 1.8k
Alice S. Mims United States 23 802 0.9× 414 0.5× 705 1.1× 261 0.5× 187 0.8× 130 1.5k
Marion Baudard France 18 686 0.8× 369 0.5× 541 0.8× 312 0.6× 176 0.7× 34 1.3k
Uta Oelschlägel Germany 22 1.2k 1.3× 488 0.6× 428 0.7× 635 1.2× 392 1.6× 53 1.8k
Anna van Rhenen Netherlands 13 696 0.8× 408 0.5× 404 0.6× 300 0.6× 124 0.5× 39 1.2k
Massimiliano Bonifacio Italy 23 979 1.1× 802 1.1× 345 0.5× 552 1.0× 417 1.7× 88 2.2k
Wencai Ma United States 16 490 0.5× 535 0.7× 872 1.4× 570 1.1× 184 0.8× 39 1.6k
Witold B. Rybka United States 21 663 0.7× 676 0.9× 254 0.4× 797 1.5× 182 0.8× 79 1.7k

Countries citing papers authored by Thomas Köhnke

Since Specialization
Citations

This map shows the geographic impact of Thomas Köhnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Köhnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Köhnke more than expected).

Fields of papers citing papers by Thomas Köhnke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Köhnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Köhnke. The network helps show where Thomas Köhnke may publish in the future.

Co-authorship network of co-authors of Thomas Köhnke

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Köhnke. A scholar is included among the top collaborators of Thomas Köhnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Köhnke. Thomas Köhnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karigane, Daiki, Amy C. Fan, Toshinobu Nishimura, et al.. (2025). Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML. Blood Cancer Discovery. 7(1). 68–84.
2.
Feng, Yang, Thomas Köhnke, Kensuke Kayamori, et al.. (2025). Inhibition of DOCK1 prevents the clonal expansion of high-risk TP53-mutant clonal hematopoiesis induced by genotoxic stressors.. Blood. 146(Supplement 1). 631–631.
3.
Köhnke, Thomas, et al.. (2024). Human ASXL1-Mutant Hematopoiesis Is Driven by a Truncated Protein Associated with Aberrant Deubiquitination of H2AK119. Blood Cancer Discovery. 5(3). 202–223. 12 indexed citations
4.
Landberg, Niklas, Thomas Köhnke, Yang Feng, et al.. (2023). IDH1 -Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood Cancer Discovery. 5(2). 114–131. 9 indexed citations
5.
Sconocchia, Tommaso, et al.. (2023). Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments. 3 indexed citations
6.
Linde, Miles H., Amy C. Fan, Thomas Köhnke, et al.. (2023). Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy. Cancer Discovery. 13(5). 1164–1185. 33 indexed citations
7.
Sconocchia, Tommaso, et al.. (2023). Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells. Journal of Visualized Experiments. 4 indexed citations
8.
Fan, Amy C., Yusuke Nakauchi, Lawrence Bai, et al.. (2023). RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. Journal of Clinical Investigation. 133(19). 4 indexed citations
9.
Thomas, Danièl, Manhong Wu, Yusuke Nakauchi, et al.. (2022). Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. Cancer Discovery. 13(2). 496–515. 39 indexed citations
10.
Sharma, Rajiv P., Daniel P. Dever, Ciaran M. Lee, et al.. (2021). The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells. Nature Communications. 12(1). 472–472. 21 indexed citations
11.
Zhang, Haijiao, Yusuke Nakauchi, Thomas Köhnke, et al.. (2020). Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia. Nature Cancer. 1(8). 826–839. 121 indexed citations
12.
Lanvers‐Kaminsky, Claudia, Maria Eveslage, Joachim Beck, et al.. (2019). Asparaginase activities during intensified treatment with pegylatedE. coliasparaginase in adults with newly-diagnosed acute lymphoblastic leukemia. Leukemia & lymphoma. 61(1). 138–145. 15 indexed citations
13.
Gentles, Andrew J., et al.. (2019). Data mining for mutation-specific targets in acute myeloid leukemia. Leukemia. 33(4). 826–843. 16 indexed citations
14.
Rothenberg‐Thurley, Maja, Susanne Amler, Dennis Göerlich, et al.. (2018). Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia. Leukemia. 32(7). 1598–1608. 106 indexed citations
15.
Rothenberg‐Thurley, Maja, Thomas Köhnke, Nikola P. Konstandin, et al.. (2017). Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia. Leukemia. 9 indexed citations
16.
Lichtenegger, Felix S., Christina Krupka, Sascha Haubner, Thomas Köhnke, & Marion Subklewe. (2017). Recent developments in immunotherapy of acute myeloid leukemia. Journal of Hematology & Oncology. 10(1). 142–142. 114 indexed citations
17.
Krupka, Christina, Thomas Köhnke, Felix S. Lichtenegger, et al.. (2016). Steroids Abrogate BiTE® Antibody Construct-Mediated Cytotoxicity in Primary AML Cells. Blood. 128(22). 3940–3940. 1 indexed citations
18.
Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2015). Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Annals of Hematology. 94(10). 1677–1688. 54 indexed citations
19.
Köhnke, Thomas, Eva Hoster, M. Hubmann, et al.. (2014). Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse. Leukemia. 29(2). 377–386. 50 indexed citations
20.
Weylandt, Karsten H., Thomas Köhnke, Christoph Schmöcker, et al.. (2008). Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1782(11). 634–641. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Éric Jourdan Breakdown of academic impact, for papers by Enkhtsetseg Purev Breakdown of academic impact, for papers by Shinichi Mizuno Breakdown of academic impact, for papers by Alice S. Mims Breakdown of academic impact, for papers by Marion Baudard Breakdown of academic impact, for papers by Uta Oelschlägel Breakdown of academic impact, for papers by Anna van Rhenen Breakdown of academic impact, for papers by Massimiliano Bonifacio Breakdown of academic impact, for papers by Wencai Ma Breakdown of academic impact, for papers by Witold B. Rybka
Rankless by CCL
2026